Cases & Deals

  • Home
  • Practices
  • Antigenics develops patent portfolio for cancer and infectious disease therapies

Share

Antigenics develops patent portfolio for cancer and infectious disease therapies

February 2008

Client(s) Antigenics, Inc.

Jones Day represented Antigenics, Inc. in the development of its patent portfolio and prosecution strategy relating to immunotherapy for cancer and infectious disease, and cancer chemotherapeutics including Oncophage® vaccine technology. This work includes counseling and participation in reexaminations and European oppositions.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.